ProfileGDS4718 / 1556662_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 43% 40% 41% 41% 43% 36% 37% 46% 45% 42% 38% 40% 43% 44% 40% 39% 42% 43% 41% 45% 41% 40% 41% 40% 43% 39% 41% 37% 46% 42% 41% 35% 44% 44% 37% 41% 43% 40% 39% 37% 46% 42% 41% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.140843
GSM549102patient 115, normal, homogenized [OPG study]5.007340
GSM549104patient 119, normal, homogenized [OPG study]5.0194741
GSM549108patient 138, normal, homogenized [OPG study]5.0902941
GSM549119patient 077, normal, homogenized [OPG study]5.1599243
GSM549133patient 032, cancer, homogenized [OPG study]4.7684936
GSM549139patient 042, cancer, homogenized [OPG study]4.8341637
GSM549099patient 107, normal, homogenized [OPG study]5.3039146
GSM549109patient 139, normal, homogenized [OPG study]5.2828145
GSM549110patient 046, normal, homogenized [OPG study]5.085342
GSM549114patient 063, normal, homogenized [OPG study]4.844938
GSM549122patient 082, normal, homogenized [OPG study]5.0015440
GSM549134patient 033, cancer, homogenized [OPG study]5.1251243
GSM549136patient 036, cancer, homogenized [OPG study]5.1211444
GSM549140patient 044, cancer, homogenized [OPG study]4.9698340
GSM549111patient 047, normal, homogenized [OPG study]4.9046539
GSM549113patient 057, normal, homogenized [OPG study]5.0337642
GSM549132patient 031, cancer, homogenized [OPG study]5.1474943
GSM549137patient 038, cancer, homogenized [OPG study]5.0012141
GSM549142patient 047, cancer, homogenized [OPG study]5.3728945
GSM549100patient 110, normal, homogenized [OPG study]5.0651541
GSM549107patient 135, normal, homogenized [OPG study]4.9755940
GSM549115patient 068, normal, homogenized [OPG study]4.9826941
GSM549116patient 072, normal, homogenized [OPG study]4.9471740
GSM549120patient 078, normal, homogenized [OPG study]5.1438743
GSM549131patient 030, cancer, homogenized [OPG study]4.8928239
GSM549118patient 074, normal, homogenized [OPG study]5.0274541
GSM549129patient 027, cancer, homogenized [OPG study]4.8858737
GSM549123patient 088, normal, homogenized [OPG study]5.261646
GSM549124patient 006, cancer, homogenized [OPG study]5.1400642
GSM549126patient 015, cancer, homogenized [OPG study]5.034741
GSM549128patient 025, cancer, homogenized [OPG study]4.7457135
GSM549103patient 117, normal, homogenized [OPG study]5.267744
GSM549117patient 073, normal, homogenized [OPG study]5.1465444
GSM549138patient 041, cancer, homogenized [OPG study]4.8272637
GSM549141patient 045, cancer, homogenized [OPG study]4.9556341
GSM549130patient 028, cancer, homogenized [OPG study]5.1454543
GSM549101patient 111, normal, homogenized [OPG study]5.0354640
GSM549105patient 128, normal, homogenized [OPG study]4.9846739
GSM549106patient 134, normal, homogenized [OPG study]4.7887937
GSM549112patient 048, normal, homogenized [OPG study]5.2838546
GSM549125patient 011, cancer, homogenized [OPG study]5.1208642
GSM549127patient 024, cancer, homogenized [OPG study]5.035141
GSM549135patient 035, cancer, homogenized [OPG study]4.8326538